Enanta Pharmaceuticals, Inc. (ENTA):企業の財務及び戦略的SWOT分析

◆英語タイトル:Enanta Pharmaceuticals, Inc. (ENTA) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
Single UserUSD300 ⇒換算¥32,400見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥64,800見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD900 ⇒換算¥97,200見積依頼/購入/質問フォーム



Enanta Pharmaceuticals, Inc. (Enanta) is a biotechnology company that discovers and develops novel inhibitors designed for use against the hepatitis C virus, or HCV. The company offers pipeline products that include HVV, a protease inhibitor; and MRSA, a bicyclolide antibiotic. Enanta’s operates with research, HCV, and Antibiotic programs. The company develops novel protease, NS5A, polymerase, and cyclophilin-based inhibitors for the treatment of hepatitis C virus; and Bicyclolides, a macrolide antibiotic, which overcomes bacterial resistance. Its antibacterial areas include superbugs, respiratory tract infections, and intravenous and oral treatments for hospital and community MRSA. It creates a new class of antibiotics, called Bicyclolides, for the treatment of multi-drug-resistant bacteria. Enanta is headquartered in Watertown, Massachusetts, the US.

Enanta Pharmaceuticals, Inc. Key Recent Developments

Dec 14, 2015: Enanta Pharmaceuticals Announces the Election of Bruce L.A. Carter, Ph.D. as Non-Executive Chairman of the Board of Directors
Nov 23, 2015: Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2015
Aug 06, 2015: Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2015
Jun 30, 2015: Enanta Pharmaceuticals Announces The Appointment Of Nathalie Adda, M.D. As Chief Medical Officer

This comprehensive SWOT profile of Enanta Pharmaceuticals, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Enanta Pharmaceuticals, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Enanta Pharmaceuticals, Inc. – Key Information
Enanta Pharmaceuticals, Inc. – Overview
Enanta Pharmaceuticals, Inc. – Key Employees
Enanta Pharmaceuticals, Inc. – Key Employee Biographies
Enanta Pharmaceuticals, Inc. – Key Operational Heads
Enanta Pharmaceuticals, Inc. – Major Products and Services
Enanta Pharmaceuticals, Inc. – History
Enanta Pharmaceuticals, Inc. – Company Statement
Enanta Pharmaceuticals, Inc. – Locations And Subsidiaries
Enanta Pharmaceuticals, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Enanta Pharmaceuticals, Inc. – Business Description
Enanta Pharmaceuticals, Inc. – Corporate Strategy
Enanta Pharmaceuticals, Inc. – SWOT Analysis
SWOT Analysis – Overview
Enanta Pharmaceuticals, Inc. – Strengths
Enanta Pharmaceuticals, Inc. – Weaknesses
Enanta Pharmaceuticals, Inc. – Opportunities
Enanta Pharmaceuticals, Inc. – Threats
Enanta Pharmaceuticals, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Enanta Pharmaceuticals, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Enanta Pharmaceuticals, Inc., Key Information
Enanta Pharmaceuticals, Inc., Key Ratios
Enanta Pharmaceuticals, Inc., Share Data
Enanta Pharmaceuticals, Inc., Major Products and Services
Enanta Pharmaceuticals, Inc., History
Enanta Pharmaceuticals, Inc., Key Employees
Enanta Pharmaceuticals, Inc., Key Employee Biographies
Enanta Pharmaceuticals, Inc., Key Operational Heads
Enanta Pharmaceuticals, Inc., Other Locations
Enanta Pharmaceuticals, Inc., Subsidiaries
Enanta Pharmaceuticals, Inc., Key Manufacturing facilities
Enanta Pharmaceuticals, Inc., Key Competitors
Enanta Pharmaceuticals, Inc., SWOT Analysis
Enanta Pharmaceuticals, Inc., Ratios based on current share price
Enanta Pharmaceuticals, Inc., Annual Ratios
Enanta Pharmaceuticals, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Enanta Pharmaceuticals, Inc., Performance Chart
Enanta Pharmaceuticals, Inc., Ratio Charts


★リサーチレポート[ Enanta Pharmaceuticals, Inc. (ENTA):企業の財務及び戦略的SWOT分析(Enanta Pharmaceuticals, Inc. (ENTA) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。